Merit Medical Systems, Inc. (MMSI)
MMSI Stock Price Chart
Explore Merit Medical Systems, Inc. interactive price chart. Choose custom timeframes to analyze MMSI price movements and trends.
MMSI Company Profile
Discover essential business fundamentals and corporate details for Merit Medical Systems, Inc. (MMSI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
14 May 1990
Employees
7.40k
Website
https://www.merit.comCEO
Martha Goldberg Aronson
Description
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
MMSI Financial Timeline
Browse a chronological timeline of Merit Medical Systems, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is $0.96, while revenue estimate is $405.28m.
Earnings released on 30 Apr 2026
EPS came in at $0.94 surpassing the estimated $0.84 by +11.90%, while revenue for the quarter reached $381.88m , beating expectations by +1.14%.
Earnings released on 24 Feb 2026
EPS came in at $1.04 surpassing the estimated $0.96 by +8.33%, while revenue for the quarter reached $393.94m , beating expectations by +1.03%.
Earnings released on 30 Oct 2025
EPS came in at $0.92 surpassing the estimated $0.82 by +12.20%, while revenue for the quarter reached $384.16m , missing expectations by -1.06%.
Earnings released on 30 Jul 2025
EPS came in at $1.01 surpassing the estimated $0.86 by +17.44%, while revenue for the quarter reached $382.46m , beating expectations by +2.96%.
Earnings released on 24 Apr 2025
EPS came in at $0.86 surpassing the estimated $0.75 by +14.82%, while revenue for the quarter reached $355.35m , beating expectations by +0.80%.
Earnings released on 25 Feb 2025
EPS came in at $0.93 surpassing the estimated $0.82 by +13.41%, while revenue for the quarter reached $355.16m , beating expectations by +1.03%.
Earnings released on 30 Oct 2024
EPS came in at $0.86 surpassing the estimated $0.80 by +7.50%, while revenue for the quarter reached $339.85m , missing expectations by -2.06%.
Earnings released on 1 Aug 2024
EPS came in at $0.92 surpassing the estimated $0.88 by +4.55%, while revenue for the quarter reached $337.58m , beating expectations by +0.90%.
Earnings released on 30 Apr 2024
EPS came in at $0.77 surpassing the estimated $0.71 by +8.45%, while revenue for the quarter reached $323.51m , beating expectations by +2.55%.
Earnings released on 28 Feb 2024
EPS came in at $0.81 surpassing the estimated $0.77 by +5.19%, while revenue for the quarter reached $323.29m , beating expectations by +1.02%.
Earnings released on 26 Oct 2023
EPS came in at $0.75 surpassing the estimated $0.65 by +15.38%, while revenue for the quarter reached $315.23m , beating expectations by +2.93%.
Earnings released on 25 Jul 2023
EPS came in at $0.81 surpassing the estimated $0.75 by +8.00%, while revenue for the quarter reached $320.06m , beating expectations by +3.09%.
Earnings released on 26 Apr 2023
EPS came in at $0.64 surpassing the estimated $0.55 by +16.36%, while revenue for the quarter reached $297.57m , beating expectations by +6.10%.
Earnings released on 22 Feb 2023
EPS came in at $0.79 surpassing the estimated $0.67 by +17.91%, while revenue for the quarter reached $293.42m , beating expectations by +1.13%.
Earnings released on 26 Oct 2022
EPS came in at $0.64 surpassing the estimated $0.53 by +20.75%, while revenue for the quarter reached $287.18m , beating expectations by +5.38%.
Earnings released on 27 Jul 2022
EPS came in at $0.73 surpassing the estimated $0.58 by +25.86%, while revenue for the quarter reached $294.98m , beating expectations by +5.14%.
Earnings released on 27 Apr 2022
EPS came in at $0.53 surpassing the estimated $0.47 by +12.77%, while revenue for the quarter reached $275.42m , beating expectations by +4.18%.
Earnings released on 24 Feb 2022
EPS came in at $0.71 surpassing the estimated $0.50 by +42.00%, while revenue for the quarter reached $278.49m , beating expectations by +2.80%.
Earnings released on 28 Oct 2021
EPS came in at $0.52 surpassing the estimated $0.44 by +18.18%, while revenue for the quarter reached $267.02m , beating expectations by +2.69%.
Earnings released on 29 Jul 2021
EPS came in at $0.62 surpassing the estimated $0.44 by +40.91%, while revenue for the quarter reached $280.33m , beating expectations by +12.40%.
MMSI Stock Performance
Access detailed MMSI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
